glp-1 news today september 29 2025 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read Paving the way for expanded

Diabetes Care 42(4):520528

So if your Part D plan covers you because you have moderate to severe sleep apnea and are over their BMI cutoff, you are not eligible for the $50/month Bridge plan

10.1016/j.jep.2015.02.026 Summary Keywords therapeutic polysaccharides of natural origin, type 2 diabetes mellitus, structural characterization, complications of type 2 diabetes mellitus, mechanism Citation Liu Z, Wang H, Gong X, Jiang X, Yang K, Jiang L, Wang Z and Tong Q (2025) Recent advances in natural polysaccharides for type 2 diabetes management: sources, structural characteristics, and mechanistic insights

Their deep expertise ensures that every patient receives the highest level of care in a comfortable and reassuring environment